Journal
NEUROPSYCHOPHARMACOLOGY
Volume 25, Issue 4, Pages 548-554Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0893-133X(01)00253-6
Keywords
d-amphetamine; sensitization; human subjects; placebo-controlled; double-blind; drug liking
Categories
Funding
- NIDA NIH HHS [DA10594] Funding Source: Medline
Ask authors/readers for more resources
Previously, we reported progressively greater behavioral responses to repeated d-amphetamine in human subjects that represented a potential model of behavioral sensitization. To extend this work, 59 healthy volunteers were randomly assigned to one of three protocols: (1) placebo administered on days 1, 3, and 5 (PPP); (2) placebo administered on days 1 and 3, and d-amphetamine (0.25 mg/kg) on day 5 (PPA); and (3) d-amphetamine administered on days 1, 3, and 5 (AAA). Comparisons were made among the three groups to determine whether repeated d-amphetamine produced an increased behavioral response. Subjective ratings of vigor and euphoria exhibited the greatest response following the third dose of the AAA group, as hypothesized. In contrast, drug liking was greatest following a single or first d-amphetamine dose. These effects were greater in women. Progressive changes in subjective responses following repeated d-ainphetamine administration may occur in healthy human subjects, although this effect may be greater for women.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available